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Abstract: Sea anemone (Cnidaria, Anthozoa) venom is an important source of bioactive 
compounds used as tools to study the pharmacology and structure-function of voltage-gated 
K+ channels (Kv). These neurotoxins can be divided into four different types, according to 
their structure and mode of action. In this work, for the first time, two toxins were purified 
from the venom of Bunodosoma caissarum population from Saint Peter and Saint Paul 
Archipelago, Brazil. Sequence alignment and phylogenetic analysis reveals that BcsTxl 
and BcsTx2 are the newest members of the sea anemone type 1 potassium channel toxins. 
Their functional characterization was performed by means of a wide electrophysiological 
screening on 12 different subtypes of Ky channels (K vl.l-K vl.6; Ky2.1; Ky3.1; Ky4.2; 
Ky4.3; /?ERG and Shaker IR). BcsTxl shows a high affinity for rKvl.2 over rKvl.6,
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hKvl.3, Shaker IR and rK vl.l, while Bcstx2 potently blocked rKvl.6 over hKvl.3, 
rK vl.l, Shaker IR and rKvl.2. Furthermore, we also report for the first time a venom 
composition and biological activity comparison between two geographically distant 
populations of sea anemones.
Keywords: sea anemone; Bunodosoma caissarum; neurotoxins; voltage-gated potassium 
channels; two-electrode voltage-clamp; Xenopus laevis; intraspecific venom variation; 
Saint Peter and Saint Paul Archipelago
1. Introduction
As the most ancient venomous animals on Earth, cnidarians (classes Anthozoa, Scyphozoa, 
Cubozoa and Hydrozoa) have evolved a large amount of pore-forming toxins, phospholipases A2, 
protease inhibitors, neurotoxins and toxic secondary metabolites [1-6], The biological and ecological 
roles of these toxins present in cnidarians venom are (1) immobilization and death of the prey, 
(2) defense against predators and (3) intra- and inter-specific competition [7-11], Sea anemones 
(Anthozoa, Actiniaria) are a well-known pharmacological source of a large number of neurotoxins 
acting upon a diverse panel of ion channels, such as voltage-gated sodium and potassium channels. 
Toxins that target sodium channels are the best-studied group, with more than 100 described toxins [12]; 
however, no more than 20 potassium channel toxins have been characterized [13],
Despite the small number of neurotoxins that have been characterized up to date, potassium channel 
toxins are valuable tools for the investigation of the physiology, pharmacology, biochemistry and 
structure-function of K+ channels, the largest and most diverse family of ion channels. Among the K+ 
channel family, 15 subfamilies can be subdivided, according to their structure and function [14], Of 
these different subfamilies, the voltage-gated potassium channel (Kv) subfamily represents one of 
them and has an essential role in repolarizing the membrane after the initiation of an action
potential [15], They are also involved in physiological processes, such as regulation of heart rate,
2 +
neuronal excitability, muscle contraction, neurotransmitter release, insulin secretion, Ca signaling, 
cellular proliferation and migration and cell volume regulation [16,17],
Sea anemone Kv channel toxins can be divided into four structural classes according to structural 
differences and activity profile. Type 1 toxins inhibit Shaker-related Kv channel currents by a 
“functional dyad” directly interacting with the channel pore. These toxins were purified from the 
venom of sea anemones belonging to the Actiniidae, Hormathiidae, Thalassianthidae and 
Stichodactylidae families [13] and were exclusively characterized on mammalian Ky channels, using
125T-lymphocyte native currents, competitive binding experiments against I-dendrotoxins and different 
transfection cell expression systems [18,19], Therefore, the biological meaning for the expression of 
these neurotoxins present in sea anemone venom still remains unknown.
The sea anemone Bunodosoma caissarum (Correa, 1964) [20] is an endemic Brazilian species and 
can be found along the entire coastline and some oceanic islands [20,21], Saint Peter and Saint Paul 
Archipelago (Saint Peter and Saint Paul Archipelago (SPSPA); N0°55', W29°20') is densely populated 
by this species, which is mostly found attached to the lower mid-littoral, as well as infra-littoral [22],
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In this study, we report for the first time the characterization of the “neurotoxic fraction” from the 
venom of B. caissarum SPSPA population, and under the same experimental conditions, we compare it 
to the population found in the state of Sao Paulo littoral (southeast coast of Brazil; S23°56', W45°20') 
(Figure 1). Furthermore, we present the purification, biochemical analyses and electrophysiological 
characterization of two new type 1 sea anemone toxins, as well as their relationship with other known 
toxins based on sequence, structural and evolutionary analyses.
Figure 1. Map showing the geographic localization of the collection sites of B. caissarum 
populations used in this study. The red circle indicates Saint Peter and Saint Paul 
Archipelago (SPSPA) location at the North Atlantic Ocean (N0°55'; W29°20'). The Red 
Cross indicates the southeast coast of Brazil (Sao Sebastiäo beach— S23°56', W45°20'), 
more than 4000 km distant from the SPSPA.
N00t>55r,W29t>20'
BRAZIL
2. Results and Discussion
2.1. Venom Purification and Biochemical Characterization o f BcsTxl and BcsTxl
Sea anemone venom extraction by electric stimulus provides a massive release of proteins, peptides 
and low molecular weight compounds from the nematocysts [23-25], When this toxic mixture is 
applied to a Sephadex G-50 gel-filtration column, the peptide content of the venom is separated from 
enzymes, such as phospholipases and cytolysin [26-28], Gel filtration of B. caissarum venom on 
Sephadex G-50 yielded five fractions named Fraction I to V (FrI-FrV) (Figure 2A), as previously 
described for the venom of B. cangicum [26] and B. caissarum population from the southeastern coast 
of Brazil [29], Gel-filtration Fraction III (Frill) from B. caissarum SPSPA population had the highest 
neurotoxicity when tested on swimming crabs (Callinectes danae) (data not shown), and it was further
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purified by reverse-phase high performance liquid chromatography (rp-HPLC) (Figure 2B). Elution 
peaks, labeled as 1 and 2 (Figure 2B), were able to fully block the insect channel Shaker IR and, thus, 
were subjected to a second purification step, leading to the pure toxins BcsTxl and BcsTx2 
(Figure 2C,D). Matrix-Assisted Laser Desorption/Ionization-Time Of Flight (MALDI-TOF) 
measurements of BcsTxl and 2 generated an m/z data of 4151.91 and 3914.521, respectively 
(Figure 2E,F). These experimental masses correspond well with the theoretical molecular masses of 
4151.93 Da of BcsTxl and 3914.80 DaforBcsTx2.
Figure 2. Isolation, purification and characterization of B. caissarum venom. (A) Gel-filtration 
chromatography of B. caissarum venom. Approximately 3.0 g of venom was injected into a 
Sephadex G-50 column, and the fractions were eluted with 0.1 M ammonium acetate 
buffer (pH 7.0). Fractions I to V were collected during UV (280 nm) monitoring.
(B) Reverse-phase high performance liquid chromatography (rp-HPLC) chromatogram of 
Fraction III resulting from gel-filtration. The peptides from Fraction (Fr) III were eluted as 
described under the Experimental Section. Peaks labeled (1 and 2) were subjected to a 
second C18 rp-HPLC chromatography. (C) Peak 1 (BcsTxl) was purified on an analytical 
C18 column using an isocratic condition of 13% of acetonitrile containing 0.1% 
trifluoroacetic acid (TFA). (D) Purification of peak 2 (BcsTx2) using an isocratic condition 
of 16% of acetonitrile containing 0.1% TFA. (E) Mass measurement of purified BcsTxl 
determined by Matrix-Assisted Laser Desorption/Ionization-Time Of Flight 
(MALDI-TOF), indicating a m/z of 2075.955 (z = 2) and 4151.91 (z = 1). (F) Mass 
spectrometry profile of purified BcsTx2 (m/z 3914.521).
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Interestingly, the venom of B. caissarum population from the Southeastern coast of Brazil shows 
hemolytic activity and one actinoporin, named Bcs I, had been purified and biochemically 
characterized [30,31], However, neither the whole venom, nor the fraction II (FrII) of SPSPA 
population (Figure 2A), showed cytolytic activity when tested on erythrocytes (data not shown). Up to 
date, cytolysin has been found in all classes of cnidarians, and more than 32 species of sea anemones 
have been reported to produce lethal cytolytic peptides [28,32], Also, it has been shown that one 
species of sea anemone (e.g., Actinia equina) can produce more than one isoform, while others are 
devoid of any cytolytic activity (e.g., Anemonia viridis) [28,33], Also, the incidence of cytolytic 
activity in corals (Anthozoa and Hydrozoa) is high, resembling the sea anemones, where cytolysins are 
widespread [32], Gunthorpe and colleagues compared the bioactivity of aqueous extracts of 
scleractinian corals (Cnidaria, Anthozoa, Hexacorallia) from different families and concluded that the 
occurrence of cytolytic activity do not differ significantly among the genera and the species 
considered, except for the extracts of colonies of Goniastrea australensis, where intraspecific 
differences were found [34],
The rp-HPLC profile of fraction III (Frill) of the SPSPA B. caissarum population yielded a very 
similar profile to that from the Southeastern coast of Brazil [35], suggesting that both populations 
releases a similar pattern of neurotoxic peptides (Figure 3). Until now, only two toxins from 
B. caissarum venom have been investigated: (i) Belli that belongs to type 1 neurotoxins and bind 
at site 3 of the voltage-gated sodium channel (Nay), delaying the inactivation process [29], and 
(ii) BcIV, which does not have its exact target determined, yet. However, experiments using crab leg 
sensory nerve suggest a Nav-activity [35], A superimposition of both rp-HPLC profiles of “neurotoxic 
fractions” from B. caissarum populations allows us to point out the following: (1) SPSPA sea anemone 
population has a BcIII-like toxin and (2), at the same retention time of BcIV, no elution peak is 
observed on the chromatographic profile of the SPSPA population. To our knowledge, such a degree 
of intraspecific variation in the peptide composition of sea anemone venom is novel.
Moran and colleagues [36,37] analyzed the evolution of a voltage-gated Na+ channel neurotoxin 
genes family from three genetically and geographically distinct populations of the sea anemone 
Nematostella vectensis [38,39] and from single specimens of Actinia equina and Anemonia viridis.
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Genomic data indicated much higher similarity among toxin genes within each species than to toxin 
genes of other species, suggesting that related neurotoxin genes family in sea anemones are subjected 
to a concerted evolution [40], The authors also demonstrated that evolution driven by positive 
Darwinian selection would have occurred, as observed by the numerous substitutions in the putative 
neurotoxin genes from A. equina and A. viridis.
Figure 3. Comparison of the “neurotoxic fraction” (Frill) from two populations of the sea 
anemone B. caissarum: southeastern coast of Brazil and Saint Peter and Saint Paul 
Archipelago. The black continuous line represents the rp-HPLC profile of Frill from the 
Southeastern coast population. Labeled peaks were the previously characterized 
neurotoxins Belli [29] and BcIV [35], Red dotted line is the Frill chromatographic profile 
of the SPSPA population. “Neurotoxic fractions” were submitted to rp-HPLC 
chromatography using a semi-preparative CAPCELL PAK C-18 column (1 x 25 cm, 
Shiseido Corp.), and their components were eluted with a linear gradient from 10% to 60% 
of acetonitrile containing 0.1% TFA, as described in the Experimental Section.
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Intraspecific diversity in the venom composition of various animal species, such as eone 
snails [41,42], bees [43], ants [44,45], spiders [46,47], scorpions [48,49] and snakes [50,51], have been 
reported using biochemical, pharmacological, proteomic and/or transcriptomic approaches. 
Abdel-Rahman and colleagues [52] used a combination of proteomic and biochemical assays to 
examine variations in the venom composition of the vermivorous Conus vexillum taken from two 
distinct geographical locations and concluded that the venom is highly diversified. Moreover, 
intraspecific variation in the peptides present in the venom from two species of fish-hunting eone 
snails (C. striatus and C. catus) has been reported. However, the venom compositions of individual 
snails of both species remained quite constant over time in captivity [42], In contrast, proteomic
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analyzes of the venom of several specimens of a piscivorous eone snail {C. consors) revealed dramatic 
variations over time, which could be related to dynamics of peptide production by the secretory 
epithelium in the venom gland [53],
Similarly to eone snails, venom variability in specimens of Tityus serrulatus scorpion, collected 
within the same geographical area, has been shown. Specimens showed venom constituent variations, 
which were related to extraction events and to dynamics in gland production and peptide 
maturation [54,55], Furthermore, investigation of intraspecific venom variation of four different 
populations of Scorpio maurus palmatus from geographically distant locations revealed highly 
significant differences among all populations and within each population studied. This may be due to 
geographic differential distribution of prey species, as well as their relative abundance in the 
environment [49,56], Also, it has been demonstrated that ontogenetic variation of viperid snakes 
(Chordata, Reptilia, Viperidae) venoms could be related to differences between the feeding habits of 
juvenile and adult snakes, suggesting that variation in venom composition may reflect natural selection 
for greater efficiency in killing and digesting different prey types within the same location or in 
different locations [57-59],
Thus, the relationship between geographic distance and patterns of venom composition implicates 
spatial scale and localized ecological and genetic factors, such as gender, elapsed time after capture, 
dynamic expression of the gland and peptide maturation, genetic variation, environmental conditions, 
seasonality and geographical locations. In the current work, these factors were not standardized (except 
for venom collection and sea anemone size, presuming a similar age of specimens of each population), 
and additional studies will be necessary in order to assess more precisely these variations in venom 
composition and to enhance our understanding of the forces driving sea anemone venom evolution.
2.2. Amino Acid Sequences and Phylogenetic Analysis
The native and non-reduced toxins were directly sequenced by automated Edman degradation, 
which gave unequivocal amino acid sequences. Cysteines were assumed as blank cycles. Sequences 
similarity indicated that BcsTx-1 and -2 are new members of the type 1 sea anemone toxins, acting on 
voltage-gated potassium channels (Kv), which also include the peptides BgK (Bunodosoma 
granulifera) [60], ShK {Stichodactyla helianthus) [61], HmK {Heteractis magnifica) [62], AsKS 
{Anemonia viridis) [63], AeK {Actinia equina) [64], AETxK {A. erythraea) [65], Kl.3-SHTX-Shala 
{S. haddoni), Kl.3-TLTX-Cala {Cryptodendrum adhaesivum), Kl.3-TLTX-Hhla {Heterodactyla 
hemprichi), Kl.3-SHTX-Sgla {S. gigantea), Kl.3-SHTX-Smla {S. mertensii), Kl.3-TLTX-Tala 
{Thalassianthus aster) [13], FC850067 {Metridium senile), FK724096, FK755121 and FK747792 
{Anemonia viridis) [66] (Figure 4A). The sequences reported as FC850067, FK724096, FK755121 and 
FK747792 are the Expressed Sequence Tags (ESTs) accession numbers of deduced mature peptide 
sequences from translated nucleotides of the above mentioned species.
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Figure 4. Phylogenetic analysis and sequence alignment. (A) Amino acid sequence of 
BcsTxl and BcsTx2 and multiple sequence alignment with the other members of type 1 sea 
anemone toxins. Alignment was based on the cysteine residues. Disulfide bridge pattern 
are indicated. Amino acid identities (black boxes) and similarities (grey boxes) are shown. 
(B) The phylogenetic tree of type 1 sea anemone Ky-toxins was constructed with the 
Neighbor-joining algorithm of MEGA 4.0. The consensus tree shown supports the 
suggested division of sea anemone type 1 into two different subtypes. The scale bar shows 
amino acid substitution rates. Only the mature region of the sequences reported as 
FC850067, FK724096, FK755121 and FK747792 were used in the analysis.
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Members of the type 1 have 35-38 amino acid residues and three disulfide bridges are paired as 
C1-C6, C2-C4 and C3-C5, by similarity. Toxins are moderately conserved, all sharing 39.5%-100% 
sequence similarity and, thus, can be further divided into subtype la, which has four amino acids 
between the second and third Cys residues from the A-terminus, and subtype lb, with eight amino 
acids [13,65], BcsTx-1 and -2, together with toxins BgK (from B. granulifera), AsKs (Anemonia viridis), 
AeK (Adina equina) and the four sequences of the mature portions of the putative toxins (from 
A. viridis m á Metridium senile), are members of subtype lb toxins (Figure 4B). Subtype la is composed 
by nine toxins (HmK, AETX-K, ShK, Kl.3-SHTX-Shala, Kl.3-TLTX-Cala, Kl.3-TLTX-Hhla, 
Kl.3-SHTX-Sgla, Kl.3-SHTX-Smla and k 1. 3-TLTX-Tala) that share more than 80% sequence identity 
with one another (Figure 4B). Type 1 toxins block potassium currents of Shaker and Shaw subfamilies 
of Ky channels and also block the intermediate conductance calcium-activated K+ channels, and they 
can differ markedly in potency or selectivity [1], Moreover, all peptides possess a conserved functional 
core composed of a key basic residue (lysine) associated with a 6.6 ± 1 Â distant key aromatic residue 
(tyrosine) [67], The side chain of the lysine residue enters the ion channel pore and is surrounded by 
four asparagine residues of the selective filter of the channel. The key aromatic residue will interact 
through both electrostatic forces and hydrogen bonding with a cluster of aromatic residues in the 
P-loop region [68,69],
Interestingly, type 1 sea anemone toxins could be classified as belonging to the six-cysteine (SXC) 
protein domain, whose first members were identified in surface coat components of the dog ascaridid 
Toxocara canis (Nematoda, Secernentea) and, later, also have been identified in many additional 
nematodes [70,71], This domain is composed of short (36 to 42 amino acids) peptides, with six 
conserved cysteines, that can be found in many parasitic nematodes, such as Ascaris suum and Necator 
americanus [72], The physiological role of these peptides has not been established, yet; however, it is 
believed that they might interfere with the local and systemic immune system and with gut muscles of 
the host [73], As already mentioned, sea anemone type 1 toxins possess a conserved “functional dyad” 
motif, which is not universally present in nematodes (Figure 5). However, if we observe the basic and 
aromatic residues (lysine and phenylalanine) of the putative protein from Ascaris suum, we might 
suggest a possible Kv channel blocker activity. Thus, considering that, throughout evolution, proteins 
found in venoms are the result of toxin recruitment events in which a protein gene involved in a 
regulatory process is duplicated and the new gene is selectively expressed in the venom apparatus [74], 
we may suppose that the existence of the SXC domain in different phyla reflect their common ancestry.
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Figure 5. Alignment. Amino acid sequences of BcsTxl and BcsTx2 were aligned with part 
of the mature portion of the putative proteins from Ascaris suum (Nematoda, Secernentea) 
(GenBank # BM281246), Necator americanus (Nematoda, Rhabditea) (GenBank 
# BG734468 and GE626467) and Nippostrongylus brasiliensis (Nematoda, Secernentea) 
(GenBank # BQ529521) after conducting a BLAST homology search of the Expressed 
Sequence Tags (ESTs) on databases.
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2.3. BcsTxl and BcsTxl Pharmacological Profiles
Sequence alignment and phylogenetic analysis (Figure 4A,B) indicated that BcsTx-1 and -2 are new 
members of the type 1 (subtype lb) toxins from sea anemones that are known to be potent inhibitors of 
Ky channels. The pharmacological profile of BcsTx-1 and -2 were determined on a wide range of 
twelve Kv channels (rKyl.l, rKv1.2, hKv1.3, rKv1.4, rKv1.5, rKv1.6, rKv2.1, rKv3.1, rKv4.2, rKv4.3, 
/?ERG and the insect channel Shaker IR; r: rat and h: human). Channels were expressed in X. laevis 
oocytes, and their currents were recorded by using two-electrode voltage-clamp technique. BcsTxl 
(0.5 pM) inhibited rK vl.l, rKvl.2, rKvl.3, rKvl.6 and Shaker IR channels with 44% ± 2%, 100%, 
100%, 88% ± 3% and 64% ± 4%, respectively (Figure 6). BcsTx2 (3 pM) showed an effect on 
potassium currents inhibiting 96% ± 2.1%, 100%, 100%, 98% ± 1.75% and 94% ± 2% of rK yl.l, 
rKyl.2, hKyl.3, rKv1.6 and Shaker IR, respectively (Figure 7). Type 1 toxins, such as BgK and ShK, 
have been extensively characterized. BgK was found to block Kvl.l-3  and Kv1.6 channels with
potencies in the nanomolar range [60], ShK was originally found to block Kv1.3 channels [69,75], but
also blocks Kyi. 1-4 and K yi.6 [61,76]; and more recently, it has been found that ShK shows activity 
against Ky3.2 channels [77], Both BgK and ShK block intermediate conductance K (Ca) channels [78], 
Some of the other type 1 toxins were indirectly assayed by competitive inhibition of the binding of
125I-dendrotoxins, allowing the conclusion that they will show activity on K yl.l, Kv1.2 and/or Kv1.6, 
since dendrotoxins only block the current of these Kv channels. The AsKs toxin has been characterized 
as a blocker of Kv1.2 current expressed in Xenopus oocytes, and no biological activity has been 
reported to FC850067, FK724096, FK755121 and FK747792 [13,62-65], Thus, it is worth mentioning 
that our work represents the first electrophysiological characterization of type 1 sea anemone toxin 
activity on cloned Shaker IR insect channel.
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Figure 6. Electrophysiological screening of BcsTxl (0.5 pM) on several cloned voltage-gated potassium channel isoforms belonging to 
different subfamilies. Representative traces under control and after application of 0.5 pM of BcsTxl are shown. The * indicates steady-state 
current traces after toxin application. The dotted line indicates the zero-current level. This screening shows that BcsTxl selectively blocks 
Kyl.x channels at a concentration of 0.5 pM.
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Figure 7. Inhibitory effects of BcsTx2 (3 pM) on 12 voltage-gated potassium channels isoforms expressed in X  laevis oocytes. 
Representative whole-cell current traces in the absence and in the presence of 3 pM BcsTx2 are shown for each channel. The dotted line 
indicates the zero-current level. The * indicates steady state current traces after application of 3 pM BcsTx2. This screening carried out on a 
large number of Kv channel isoforms belonging to different subfamilies shows that BcsTx2 selectively blocks Shaker channels subfamily.
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In order to characterize the potency and selectivity profile, concentration-response curves were 
constructed for BcsTxl. IC50 values yielded 405 ± 20.56 nanomolar (nM) for rK vl.l, 0.03 ± 0.006 nM 
for rKvl.2, 74.11 ± 20.24 nM for hKvl.3, 1.31 ± 0.20 nM for rKvl.6 and 247.69 ± 95.97 nM for 
Shaker IR (Figure 8A and Table 1). A concentration-response curve was also constructed to determine 
the concentration at which BcsTx2 blocked half of the channels. The IC50 values calculated are 
14.42 ± 2.61 nM for rK yl.l, 80.40 ± 1.44 nM for rKv1.2, 13.12 ± 3.29 nM for hKv1.3, 7.76 ± 1.90 nM 
for rKyl.6 and 49.14 ± 3.44 nM for Shaker IR (Figure 8B and Table 1). Similar to BgK, the BcsTx-1 
and -2 potencies are within the nanomolar range and are more potent when compared to type 2 sea 
anemone toxins, such as kalicludines (AsKCl-3), which blocks Kv1.2 channels with IC50 values 
around 1 pM [63], In general, previous work has shown that type 1 sea anemone toxins are more 
potent than type 2, and it has been proposed in the literature that toxins with a “functional dyad” are 
more potent, because it provides a secondary anchoring point, contributing to a higher toxin 
affinity [68,79], However, APEKTxl, a type 2 toxin from A. elegantissima, is a selective blocker of 
Kv 1.1, with an IC50 value of 1 nM, and the existence of a “functional dyad” has not been shown [80], 
Moreover, the electrophysiological characterization of the scorpion toxins Pil and Tc32 (from 
Pandinus imperator and Tityus camhridgei, respectively), which are known to potently inhibit Kyi 
channels, suggested that other amino acids, rather than those of the “functional dyad”, are also 
involved in both potency and selectivity of the Ky channel isoforms [81,82], Although, it is worth 
noting that the “functional dyad” of a-KTx family of scorpion toxins is very important for high affinity 
block and selectivity [83], For instance, toxin Pi2 (a-KTx7.1), from the venom of P. imperator, has a 
“functional dyad” formed by Lys27 and Trp8 and is able to block K yi.2 current with an IC50 value 
(0.032 nM) comparable to BcsTxl [84], Also, MgTX (a-KTx2.2) toxin, from Centruroides 
margaritatus, binds with very high affinity to K yi.6 (IC50 value of 5 nM), and the role of the side 
chain of the dyad lysine (Lys27) as a critical residue to the binding of the toxin to the ion conduction 
pathway of the channel was proposed [85],
In order to elucidate whether BcsTx-1 and -2 block the current through a physical obstruction of the 
Shaker IR channel pore or act as gating modifiers, current-voltage (I-V) experiments were performed. 
The currents were inhibited at the test potentials from -90 to 100 mV, and the inhibition was not 
associated with a change of the shape of the I-V relationship. The control curve and the curve in the 
presence of BcsTxl (500 nM) were characterized by a V 1/2 values of 20.85 ± 0.69 mV and 
22.62 ± 0.73 mV, respectively. Moreover, the control curve and the curve in the presence of BcsTx2 
(50 nM) were characterized by a V 1/2 values of 18.49 ± 1.49 mV and 23.88 ± 1.57 mV, respectively. 
The V1/2 of activation was not significantly shifted (p < 0.05), and thus, channel gating was not altered 
by BcsTxl and BcsTx2 binding (Figure 8C,D). Additionally, BcsTx-1 and -2 shows a non-dependence 
of voltage for the blockage on a wide range from -10 mV to 50 mV (Figure 8E,F); the blockage effect 
was reversible, and a complete recovery was observed after washout, suggesting an extracellular site of 
action (Figure 8G,H). To date, type 1 sea anemone toxins have been described to act solely through a 
Ky channel pore-blocking mechanism [1],
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Figure 8. Functional features of BcsTxl and BcsTx2 on Ky channels. (A, B) Dose-response 
curves of BcsTxl and BcsTx2 on rK yl.l, rKyl.2, hKyl.3, rKyl.6 and Shaker IR channels. 
The curves were obtained by plotting the percentage blocked current as a function of 
increasing toxin concentrations. All data are presented as the mean ± standard error (// > 3). 
(C, D) Current-voltage relationship for Shaker IR isoform in control condition and in the 
presence of BcsTxl (500 nM) and BcsTx2 (50 nM). Current traces were evoked by 10 mV 
depolarization steps from a holding potential o f -90 mV. Open circles indicates the V1/2 in 
control; closed circles indicate the addition of toxins. (E, F) Percentage of currents left 
after application of BcsTxl (500 nM) and BcsTx2 (50 nM) on Shaker IR channel. In a 
range of test potentials from -10 mV to +50 mV, no difference was observed in the degree 
of BcsTxl- and BcsTx2-induced blockage. (G, H) Representative experiment of the time 
course of Shaker IR current inhibition with BcsTxl (500 nM) and BcsTx2 (3000 nM) and 
the reversibility hereof. Control (open square); washout (open circles). Blockage occurred 
rapidly, and binding was reversible upon washout. Plots shown are a representative of at 
least three individual experiments.
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Table 1. BcsTxl and BcsTx2 IC50 values in nanomolar (nM).
Isoforms BcsTxl BcsTx2
K yl.l 405 ±20.56 14.42 ±2.61
Kyl.2 0.03 ± 0.006 80.40 ± 1.44
Kyl.3 74.11 ±20.24 13.12 ± 3.29
K yi.6 1.31 ±0.20 7.76 ± 1.90
Shaker IR 247.69 ±95.97 49.14 ±3.44
2.4. Bioinformatics Analysis 
Molecular Models of BcsTx-1 and -2
Venomous animals produce a wide variety of neurotoxins with different types of amino acid 
sequences, secondary structures and disulfide bridge frameworks, and none of them is definitively 
associated with a particular animal species or ion channel selectivity [79], Type 1 sea anemone toxins 
are associated with the aa type of family fold. BgK toxin has a “helical cross-like” motif in which one 
a-helix is disposed perpendicular to the others [67] (Figure 9A) and ShK has a “helical capping” motif 
(3i0aa), since one a-helix (formed by three amino acid residues) caps the other two helical 
structures [86], The molecular models of BcsTx-1 and -2 (Figure 9B,C) were constructed using BgK as 
template, and the quality of the models were analyzed using PROCHECK [87], BcsTx-1 and -2 share 
55.3% and 62% of sequence identity with BgK, respectively. BcsTxl and BcsTx2 analyses revealed 
that 87.1% and 90.0% of residues are located in the most favored regions, 12.9% and 6.7% are located 
in additionally allowed regions and 0% and 3.3% are located in generously allowed regions of the 
Ramachandran diagram, respectively [88], The secondary structure of both toxins consists of three 
a-helical segments; the first a-helix comprises the amino acids 8-17, the second comprises the residues 
24-29 and the third a-helix consists of the amino acids 31-34. Despite the overall moderate identity 
between these three toxins, the residues of the second and third a-helices are highly identical. BgK 
second a-helix shares 83.3% and 100% of identity to BcsTx-1 and -2, respectively, and the third is 
100% identical within the three toxins.
Mar. Drugs 2013, 11 670
Figure 9. 3-D model representation of BcsTxl and BcsTx2. Models were constructed 
using BgK toxin as template (Protein Data Bank (PDB) code 1BGK). (A) Ribbon 
representation of nuclear magnetic resonance (NMR) structure of BgK. Amino acid 
sequence and secondary structure: a-helix (red) and loops (gray). (B ) Stereoscopic 3-D 
model of BcsTxl. (C) BcsTx2 molecular model.
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3. Experimental Section
3.1. Sea Anemone Collection, Venom Isolation and Neurotoxins Purification
Specimens of the sea anemone Bunodosoma caissarum (3.5-4.0 cm of diameter) were collected at 
the Saint Peter and Saint Paul Archipelago (N0°55', W29°20'), Brazil. The sea anemones were 
maintained in aquarium for 24 h, and then the venom was obtained by electrical stimulation of the 
animals, according to the method of Malpezzi et al. [23], The venom was fractionated first by 
gel-filtration chromatography using a Sephadex G-50 column (1.9 x 131 cm, GE Healthcare, Uppsala, 
Sweden), and afterwards, the fraction containing the neurotoxic peptides was submitted to 
reverse-phase HPLC chromatography in an ÄKTA Purifier system (GE Healthcare, Uppsala, Sweden) 
using a semi-preparative CAPCELL PAK C-18 column (1 x 25 cm, Shiseido Corp., Kyoto, Japan). 
Elution was done in a linear gradient from 10% to 60% of acetonitrile containing 0.1% TFA at a flow 
rate of 2.5 mL/min during 40 min, and the peptides were monitored at UV 214 nm. Pure BcsTxl and 
BcsTx2 were obtained using an analytical CAPCELL PAK C-18 column (0.46 x 15 cm, Shiseido 
Corp., Kyoto, Japan) and different gradients of the solvent described above, at a flow rate of 1 
mL/min. The protein content of the pure peptides was estimated by the bicinchoninic acid assay (BCA) 
method (Pierce, Rockford, IL, USA).
3.2. Mass Spectrometry Analysis
Mass spectrometry analyses were performed on an Ultraflex II TOF/TOF MALDI (Bruker 
Daltonics, Bremen, Germany) equipped with Nd-YAG Smartbeam laser (MLN 202, LTB) under 
reflectron mode. The laser frequency was adjusted to 50 Hz. The matrix, a-cyano-4-hydroxycinnamic 
acid (Sigma-Aldrich Co., St. Louis, MO, USA), was prepared at a concentration of 20 mg/mL in 
1:1 acetonitrile containing 0.1% TFA solution. External calibration was performed using peptide 
calibration standard II (Bruker Daltonics, Bremen, Germany). Sample solution (1 pL) dropped onto the
Mar. Drugs 2013, 11 671
MALDI sample plate was added to the matrix solution (1 pL) and dried at room temperature. Data 
were analyzed using the FlexAnalysis 3.0 program (Bruker Daltonics, Bremen, Germany).
3.3. Amino Acid Sequence Determination
Samples of the native peptides (BcsTxl and BcsTx2) (50-200 pmol) were sequenced by Edman 
degradation using the automated PPSQ-33A protein sequencers (Shimadzu, Kyoto, Japan) coupled to 
reverse phase separation of phenylthiohydantoin (PTH)-amino acids on a WAKOSIL-PTH (4.6 x 250 mm) 
column (Wako, Osaka, Japan), according to the manufacturer’s instructions.
3.4. Expression o f Voltage-Gated Ion Channels in Xenopus laevis Oocytes
Stage V-VI of X. laevis oocytes were harvested by partial ovariectomy under anesthesia 
(3-aminobenzoic acid ethyl ester methanesulfonate salt, 0.5 g/L from Sigma-Aldrich Co., Saint Louis, 
MO, USA). The oocytes were defolliculated for 2 h by treatment with 2 mg/mL collagenase 
(Sigma-Aldrich Co., Saint Louis, MO, USA) in Ca2+ free ND96 solution (in mM: 96 NaCl; 2 KC1; 
1 MgCh; 5 HEPES adjusted pH 7.4). For the expression of Ky channels (Ky i . 1-Ky 1 ,6, Ky2.1, Ky3.1, 
Kv4.2, Kv4.3, /?ERG and the insect channel Shaker IR), the linearized plasmids were transcribed using 
the T7 or SP6 mMessage-mMachine transcription kit (Ambion, Austin, TX, USA). Oocytes were 
injected with 50 nL of cRNA at a concentration of 1 ng/nL using a microinjector (Drummond Scientific, 
Broomall, PA, USA). The oocytes were maintained in a ND96 solution (in mM: 96 NaCl, 2 KC1,
1.8 CaCh, 2 MgCh and 5 HEPES; adjusted pH 7.4), supplemented with 50 pg/mL gentamicin sulfate.
3.5. Electrophysiological Recordings
Two-electrode voltage-clamp recordings were performed at room temperature (18-22 °C) using a 
Geneclamp 500 amplifier (Molecular Devices, Sunnyvale, CA, USA) controlled by a pClamp data 
acquisition system (Axon Instruments, Union City, CA, USA). Whole-cell currents from oocytes were 
recorded from 1 to 3 days after injection. Bath solution was the same ND96 solution described above. 
Voltage and current electrodes were filled with 3 M KCl. Resistances of both electrodes were kept 
between 0.8 and 1.0 QM. The elicited currents were filtered at 500 Hz using a four-pole lowpass 
Bessel filter. Leak subtraction was performed using a -P /4  protocol. Kv l . l - K v 1.6 and Shaker IR 
currents were evoked by 500 ms depolarizations to 0 mV, followed by a 500 ms pulse to -50  mV, 
from a holding potential of -90 mV. Current traces of /?ERG channels were elicited by applying a 
+40 mV prepulse for 2 s, followed by a step to -120 mV for 2 s. Ky3.1, Ky 4.2 and Ky4.3 currents 
were elicited by 500 ms pulses to +20 mV from a holding potential of -90 mV. To assess the 
concentration-response relationships, data were fitted with the Hill equation:
y=  100/[ 1 + (EC50/[toxin])/i] (1)
where y  is the amplitude of the toxin-induced effect, EC50 is the toxin concentration at half maximal 
efficacy, [toxin] is the toxin concentration and h is the Hill coefficient. In order to investigate the 
current-voltage relationship, current traces were evoked by 10 mV depolarization steps from a holding 
potential o f -90 mV. The activation curves were fitted with a Boltzmann relationship of the form:
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where V1/2 is the voltage for half-maximal activation and 5  is the slope factor. The activation kinetics 
were obtained by mono-exponential fits to the raw current traces.
3.6. Phylogenetic Analysis and Sequence Alignment
The functional dendrogram reported here was constructed using the Neighbor-joining method [89] 
of the publicly available software MEGA4 [90], A multiple sequence alignment of BcsTx-1 and -2 and 
sea anemone type 1 voltage-gated potassium channel toxins was done with ClustalW2 (http://www.ebi. 
ac.uk/Tools/msa/clustalw2 [91]). Sequences analyzed were that of Aek (=Swiss-Prot # P81897) from 
the venom of the sea anemone Actinia equina [64], AETX-K (=Swiss-Prot # Q0EAE5) from Anemonia 
erythraea [65], AsKs (=Swiss-Prot # Q9TWG1), from Anemonia sulcata [63], Bgk (=Swiss-Prot 
#P29186) from Bunodosoma granulifera [60], HmK (=Swiss-Prot #016846) from Radianthus 
magnifica [62], Kl.3-SHTX-Shala (=GenBank # AB595205) from Stichodactyla haddoni [13,92], 
Kl.3-TLTX-Cala (=GenBank # AB595207) (Cryptodendrum adhaesivum), Kl.3-TLTX-Hhla 
(=GenBank # AB595208) (Heterodactyla hemprichi), Kl.3-SHTX-Sgla (=GenBank # AB595204) 
{Stichodactyla gigantea), Kl.3-SHTX-Smla (=GenBank # AB595206) {Stichodactyla mertensii) and 
k 1. 3-TLTX-Tala (=GenBank # AB595209) {Thalassianthus aster) [13], ShK (=Swiss-Prot # P29187) 
from Stichodactyla helianthus [61], FK724096, FK755121 and FK747792 from Anemonia viridis [66] 
and FC850067 from Metridium senile. The tree shown is a bootstrap consensus based upon 
1000 replications of the Neighbor-joining algorithm with Poisson correction. Numbers are 
bootstrap percentages.
3.7. Structure Computational Modeling
3D-structures of B. caissarum toxins were modeled using the publicly available program 
MODELLER9vlO [93], BcsTx-1 and -2 were modeled using as template BgK, a voltage-gated 
potassium channel toxin from the venom of the sea anemones Bunodosoma granulifera (PDB code: 
1BGK). Models were refined based on predicted secondary structure using SCRATCH Protein 
Predictor [94] and PROCHECK [87],
3.8. Statistical Assessment
Comparison of two sample means was made using a paired Student’s t test {p < 0.05). All data 
represent at least three independent experiments {n > 3) and are presented as the mean ± standard error. 
All data were analyzed using Clampfit 10.3 (Molecular Devices, Sunnyvale, CA, USA) and Origin 7.5 
software (Origin Lab., Northampton, MA, USA).
4. Conclusions
In summary, we demonstrate, for the first time, a venom composition and biological activity 
comparison between two geographically distant populations of sea anemones. Moreover, this is the 
first electrophysiological characterization of a sea anemone type 1 toxin on cloned Shaker IR insect 
channels, allowing us to suggest that the role of these toxins in the physiology of the sea anemone
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would be related with predation and defense against predators and highlights the possible application 
of these peptides as tools for research in neuroscience, as well as in the development of novel insecticides.
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